Alunbrig (Brigatinib) is used for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC.

ALUNBRIG is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Alunbrig (Brigatinib) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of Alunbrig (Brigatinib) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the ALUNBRIG (brigatinib) tablets cost price in India.

The order for Alunbrig (Brigatinib) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Brigatinib (marketed as Alunbrig) is a small-molecule targeted cancer therapy being developed by ARIAD Pharmaceuticals, Inc. Brigatinib acts as both a anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR) inhibitor. Brigatinib could overcome resistance to osimertinib conferred by the EGFR C797S mutation if it is combined with an anti-EGFR antibody such as cetuximab or panitumumab.

ALUNBRIG (brigatinib) tablets, for oral use. Initial U.S. Approval: 2017

Generic Name: brigatinib

Alunbrig (brigatinib)

ALUNBRIG (brigatinib) tablets, for oral use is available.

Get In Touch

Alunbrig (Brigatinib) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Alunbrig (Brigatinib) on prescription and Import License in Patient's Name only.

For overseas patients, Alunbrig (Brigatinib) can be made available in Send your enquiry to find Alunbrig (Brigatinib) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for Alunbrig (Brigatinib).

For Alunbrig (Brigatinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Takeda says cancer drug Alunbrig shows longer benefit vs crizotinib For More Details

Takeda Presents Long-Term Data in ALK+ NSCLC Showing ALUNBRIG® (brigatinib) Continues to Demonstrate Superiority in the First-Line After Two Years of Follow-Up For More Details

Channel Partner In India

Delhi Office

60/4, T&T House. Yusuf Sarai,
New Delhi:110016

Bangalore Office

#308, Raheja Chambers, 12,
Museum Road, Bangalore 560 001

Kolkata Office

1/A R.G Kar Road, Shayambazar,
Kolkata 700004

Lucknow Office

203-A, 2nd Floor, Tower -11, Felix
Square, IBB-2, Sushant Golf city, Lucknow 226030